The trajectory of companies tied to blockbuster drugs like Viagra presents a nuanced investment landscape . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the expiry in key markets has introduced considerable uncertainty . Investors are now facing the impact of lower-cost alternatives